Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis

MeSH terms

• Clinical Protocols
• Demyelinating Diseases / diagnosis*
• Demyelinating Diseases / drug therapy*
• Early Diagnosis
• Humans
• Immunosuppressive Agents / adverse effects
• Immunosuppressive Agents / therapeutic use*
• Magnetic Resonance Imaging / standards
• Multiple Sclerosis / diagnosis*
• Multiple Sclerosis / drug therapy*
• Patient Selection*
• Predictive Value of Tests
• Prognosis
• Randomized Controlled Trials as Topic / standards
• Time Factors
• Treatment Outcome